
Protein bars recalled after hairnet and shrink wrap found in products
Recalled Burn Boot Camp snacks were sold at locations run by gym franchises throughout the U.S.
Watch CBS News
Kate Gibson is a Reporter for CBS MoneyWatch in New York, where she covers business and consumer finance. She previously worked for CNBC and MarketWatch and has written for national news outlets, including Barron's, the Wall Street Journal and the Chicago Tribune.
Recalled Burn Boot Camp snacks were sold at locations run by gym franchises throughout the U.S.
FDA finds reasonable expectation of effectiveness for drug designed to keep bigger breeds around longer, biotech firm says.
Fast-food prices have gone up faster than groceries, with McDonald's seeing fewer low-income customers as a result.
Andy Stone, media communications director for Meta, listed on online database maintained by Russia's interior ministry.
Lawsuit alleges the Canadian executive directed underlings to recruit potential victims, including minors, with modeling offers.
Paris Hilton's 11:11 Media is pausing an exclusive ad campaign on X following Elon Musk's tweet endorsing an antisemitic conspiracy theory.
Vermont company recalls all of its Wilcox brand ice cream, yogurt and ice cream bars, as well as Leonardo's brand gelato.
The American Academy of Ophthalmology says people with conditions like glaucoma should continue taking prescription eye drops.
CDC investigating fruit from HMC Farms after one person died and 10 are hospitalized following a listeria outbreak.
Employees demanding return of former boss tell OpenAI board to resign, threatening to leave and follow the ousted CEO to Microsoft otherwise.
OpenAI said its board concluded Altman "was not consistently candid in his communications." Mira Murati will step in as interim CEO.
Amazon customers, who can peruse showrooms and compare prices, will soon be able to use the e-commerce site to buy Hyundai vehicles.
Unionized Starbucks employees stage flash strike on "Red Cup Day" in protest over staff shortages and other workplace issues.
More than two dozen types of eye drops are involved in 2023's latest recall, according to a notice posted by the FDA.
Kilitch Healthcare India is recalling the products more than three weeks after the FDA warned against their use.